230 related articles for article (PubMed ID: 10287653)
1. Biological indicator test packs: a survey of user practices.
Smith DE
J Healthc Mater Manage; 1988; 6(4):38, 40-2. PubMed ID: 10287653
[No Abstract] [Full Text] [Related]
2. Test packs. Making your own vs. buying commercially.
Caporino P
J Healthc Mater Manage; 1988; 6(4):32-5. PubMed ID: 10287652
[No Abstract] [Full Text] [Related]
3. A study of sterilization containers.
Kneedler JA; Gattas M
J Healthc Mater Manage; 1988; 6(4):24-8, 30. PubMed ID: 10287651
[TBL] [Abstract][Full Text] [Related]
4. Statewide test of a new postmarketing drug surveillance system.
Fisher S; Bryant SG; Solovitz BL; Kluge RM
Tex Med; 1987 Aug; 83(8):59-62. PubMed ID: 3660262
[No Abstract] [Full Text] [Related]
5. The desire to regulate: the wish to discover.
Lasagna L
Drugs Exp Clin Res; 1987; 13(11):659-64. PubMed ID: 3443041
[TBL] [Abstract][Full Text] [Related]
6. Steam sterilization trends in the U.S.A.
Young J; Schmidt WC
J Sterile Serv Manage; 1987 Jun; 5(1):30-2. PubMed ID: 10283157
[TBL] [Abstract][Full Text] [Related]
7. [Postmarketing surveillance of drugs].
Simon P; Soubrié C
Rev Prat; 1983 Jan; 33(1-2):23-8. PubMed ID: 6823538
[No Abstract] [Full Text] [Related]
8. Critical reflection on the collection and evaluation of adverse drug reaction data.
Venulet J
Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S48-53. PubMed ID: 3842691
[No Abstract] [Full Text] [Related]
9. What you should know about FDA-USP Drug Product Problem Reporting Program.
McGinnis DM
Pharm Times; 1986 Apr; 52(4):101-4, 109. PubMed ID: 10276472
[No Abstract] [Full Text] [Related]
10. Adverse drug reaction reporting.
Bosco LA
Am J Gastroenterol; 1987 Apr; 82(4):356-7. PubMed ID: 3565343
[No Abstract] [Full Text] [Related]
11. Revised ADR report permits internal review of drug experience.
Jeffrey LP
Pharm Times; 1986 Dec; 52(12):48-50. PubMed ID: 10317827
[No Abstract] [Full Text] [Related]
12. CS survey: are you equipped?
Souhrada L
Mater Manag Health Care; 1993 Mar; 2(3):16, 18, 20. PubMed ID: 10125537
[No Abstract] [Full Text] [Related]
13. Round table: Post-marketing evaluation of fertility-regulating drugs as viewed by the pharmaceutical industry.
Hum Reprod; 1987 Apr; 2(3):241-63. PubMed ID: 3597744
[No Abstract] [Full Text] [Related]
14. Are sterilization containers cost-effective?
Becker GE
J Healthc Mater Manage; 1992 Jul; 10(6):42-4, 46. PubMed ID: 10119231
[No Abstract] [Full Text] [Related]
15. [Critical study of methods of postmarketing drug surveillance].
Gut JP; Auriche M; Spriet-Pourra C; Juillet Y
Therapie; 1985; 40(5):313-9. PubMed ID: 3913048
[No Abstract] [Full Text] [Related]
16. Assessing the OR's sterilization quality control.
Patterson P
OR Manager; 1988 Mar; 4(3):1,6-8. PubMed ID: 10286083
[No Abstract] [Full Text] [Related]
17. EtO alternatives. Other technologies.
J Healthc Mater Manage; 1989 Jul; 7(5):52. PubMed ID: 10293996
[No Abstract] [Full Text] [Related]
18. Postmarketing studies of drug efficacy.
Strom BL; Melmon KL; Miettinen OS
Arch Intern Med; 1985 Oct; 145(10):1791-4. PubMed ID: 3899034
[No Abstract] [Full Text] [Related]
19. Rational product evaluation.
Larson E; Maciorowski L
J Nurs Adm; 1986; 16(7-8):31-6. PubMed ID: 3637222
[TBL] [Abstract][Full Text] [Related]
20. [Industrial drug-surveillance. Spontaneous notification: data collection, survey].
Trunet P
Rev Med Interne; 1986 Nov; Spec No():35-9. PubMed ID: 3809778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
